10 likes | 87 Views
This study examines splicing pathway mutations in myelodysplasia through analyzing samples from a cohort of 5, 7, 37, 56, 5, 79, and 23 patients, shedding light on potential implications for disease progression and management.
E N D
Splicing pathway mutations in myelodysplasia (N = 5 ) (N = 7 ) (N = 37 ) (N = 56 ) (N = 5 ) (N = 79 ) (N = 23 ) (N = 7 )